المؤلفون: Lampert EJ; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Zimmer A; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Padget M; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Cimino-Mathews A; Department of Pathology, The Johns Hopkins Medical Institution, Baltimore, Maryland., Nair JR; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Liu Y; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Swisher EM; Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology, University of Washington, Seattle, Washington., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Nixon AB; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Nichols E; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, Maryland., Bagheri MH; Department of Radiology and Imaging Sciences, Clinical Center, National Cancer Institute, Bethesda, Maryland., Levy E; Interventional Radiology, NIH Clinical Center, Bethesda, Maryland., Radke MR; Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology, University of Washington, Seattle, Washington., Lipkowitz S; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Taube JM; Department of Dermatopathology, The Johns Hopkins Medical Institution, Baltimore, Maryland., Steinberg SM; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Lee JM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. leej6@mail.nih.gov.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Aug 15; Vol. 26 (16), pp. 4268-4279. Date of Electronic Publication: 2020 May 12.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , B7-H1 Antigen/*genetics , Ovarian Neoplasms/*drug therapy , Phthalazines/*administration & dosage , Piperazines/*administration & dosage , Poly(ADP-ribose) Polymerases/*genetics, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/adverse effects ; Chemokine CXCL10/genetics ; Chemokine CXCL9/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immune Checkpoint Inhibitors/administration & dosage ; Immune Checkpoint Inhibitors/adverse effects ; Interferon-gamma/genetics ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/pathology ; Phthalazines/adverse effects ; Piperazines/adverse effects ; Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage ; Poly(ADP-ribose) Polymerase Inhibitors/adverse effects ; Progression-Free Survival ; Vascular Endothelial Growth Factor A/genetics

المؤلفون: Friedman J; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Moore EC; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Zolkind P; Department of Otolaryngology-Head and Neck Surgery, Washington University in St. Louis, St. Louis, Missouri., Robbins Y; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Clavijo PE; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Sun L; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Greene S; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Morisada MV; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Mydlarz WK; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland., Schmitt N; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland., Hodge JW; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Schreiber H; Department of Pathology, University of Chicago, Chicago, Illinois., Van Waes C; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Uppaluri R; Department of Surgery/Otolaryngology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts., Allen C; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland. clint.allen@nih.gov.; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Feb 01; Vol. 26 (3), pp. 679-689. Date of Electronic Publication: 2019 Oct 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*pharmacology , Immunodominant Epitopes/*immunology , Mouth Neoplasms/*immunology , Neoadjuvant Therapy/*methods , Programmed Cell Death 1 Receptor/*antagonists & inhibitors , T-Lymphocytes/*immunology, Animals ; Cell Line, Tumor ; Humans ; Immunotherapy/methods ; Mice ; Mice, Inbred C57BL ; Mouth Neoplasms/drug therapy ; Mouth Neoplasms/pathology ; Programmed Cell Death 1 Receptor/immunology ; Tumor Microenvironment/immunology ; Xenograft Model Antitumor Assays

المؤلفون: Fujii R; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B13, Bethesda, MD, 20892, USA., Jochems C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B13, Bethesda, MD, 20892, USA., Tritsch SR; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B13, Bethesda, MD, 20892, USA., Wong HC; Altor BioScience Corporation, 2810 North Commerce Parkway, Miramar, FL, 33025, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B13, Bethesda, MD, 20892, USA., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B13, Bethesda, MD, 20892, USA. jh241d@nih.gov.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2018 Apr; Vol. 67 (4), pp. 675-689. Date of Electronic Publication: 2018 Feb 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , Cytotoxicity, Immunologic/*immunology , Interleukin-15/*immunology , Killer Cells, Natural/*immunology , Neoplasms/*immunology , Receptors, Interleukin-15/*immunology , Recombinant Fusion Proteins/*immunology , Transforming Growth Factor beta1/*pharmacology, Antibody-Dependent Cell Cytotoxicity ; Humans ; Immunosuppression Therapy ; Killer Cells, Natural/drug effects ; Lymphocyte Activation ; Neoplasms/therapy ; Tumor Cells, Cultured

المؤلفون: Jochems C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Fantini M; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Tsang KY; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Vandeveer AJ; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gulley JL; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

المصدر: International journal of cancer [Int J Cancer] 2017 Aug 01; Vol. 141 (3), pp. 583-593. Date of Electronic Publication: 2017 May 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*pharmacology , Antibody-Dependent Cell Cytotoxicity/*immunology , Interleukin-2/*metabolism , Killer Cells, Natural/*immunology , Lymphoma, Non-Hodgkin/*immunology , Receptors, IgG/*metabolism, Antibodies, Monoclonal, Humanized ; Apoptosis ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/metabolism ; Cell Proliferation ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/metabolism ; Humans ; Immunoglobulin G/pharmacology ; Interleukin-2/genetics ; Lymphoma, Non-Hodgkin/metabolism ; Lymphoma, Non-Hodgkin/pathology ; Lymphoma, Non-Hodgkin/therapy ; Male ; Middle Aged ; Receptors, IgG/genetics ; Tumor Cells, Cultured

المؤلفون: Nagaya T; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Nakamura Y; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Sato K; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Harada T; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Choyke PL; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Kobayashi H; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America.

المصدر: Oncotarget [Oncotarget] 2017 Jan 31; Vol. 8 (5), pp. 8807-8817.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Infrared Rays*, Adenocarcinoma/*therapy , Adenocarcinoma, Papillary/*therapy , Antibodies, Monoclonal/*pharmacology , Antineoplastic Agents, Immunological/*pharmacology , B7-H1 Antigen/*antagonists & inhibitors , Immunotherapy/*methods , Lung Neoplasms/*therapy , Phototherapy/*methods, Adenocarcinoma/immunology ; Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Adenocarcinoma of Lung ; Adenocarcinoma, Papillary/immunology ; Adenocarcinoma, Papillary/metabolism ; Adenocarcinoma, Papillary/pathology ; Animals ; Antibodies, Monoclonal, Humanized ; B7-H1 Antigen/immunology ; B7-H1 Antigen/metabolism ; Cell Line, Tumor ; Dose-Response Relationship, Drug ; Female ; Fluorescent Dyes/pharmacology ; Humans ; Lung Neoplasms/immunology ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Mice, Nude ; Time Factors ; Tumor Burden ; Xenograft Model Antitumor Assays

المؤلفون: Fujii R; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Friedman ER; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Richards J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Tsang KY; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Heery CR; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

المصدر: Oncotarget [Oncotarget] 2016 Jun 07; Vol. 7 (23), pp. 33498-511.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*pharmacology , Antibody-Dependent Cell Cytotoxicity/*drug effects , Antineoplastic Agents/*pharmacology , Chordoma/*immunology, Antibodies, Monoclonal, Humanized ; B7-H1 Antigen/antagonists & inhibitors ; Cell Line, Tumor ; Humans ; Lymphocyte Activation/drug effects

المؤلفون: Chakraborty M; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B09, Bethesda, MD 20892, USA., Gelbard A, Carrasquillo JA, Yu S, Mamede M, Paik CH, Camphausen K, Schlom J, Hodge JW

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2008 Aug; Vol. 57 (8), pp. 1173-83. Date of Electronic Publication: 2008 Feb 07.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0340-7004 (Print) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Cancer Vaccines/*therapeutic use , Hematologic Neoplasms/*radiotherapy , Radioimmunotherapy/*methods, Animals ; Antibodies, Monoclonal/pharmacokinetics ; Antigens, Neoplasm/immunology ; Cancer Vaccines/pharmacokinetics ; Cell Line, Tumor ; Mice ; Mice, Transgenic ; Sensitivity and Specificity ; Tissue Distribution ; Treatment Outcome ; Up-Regulation/immunology ; Yttrium Radioisotopes/pharmacokinetics ; Yttrium Radioisotopes/therapeutic use ; fas Receptor/immunology

المؤلفون: Chakraborty M; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive Room 8B09, Bethesda, MD 20892, USA., Schlom J, Hodge JW

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2007 Sep; Vol. 56 (9), pp. 1471-84. Date of Electronic Publication: 2007 Feb 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0340-7004 (Print) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Drug Synergism* , Lymphocyte Activation*, Antibodies, Monoclonal/*pharmacology , Cancer Vaccines/*pharmacology , Immunization/*methods , Neoplasms/*therapy , T-Lymphocytes/*immunology , Vaccinia virus/*genetics, Animals ; Antibody Affinity ; Antigens, CD/drug effects ; Antigens, Differentiation/drug effects ; CTLA-4 Antigen ; Cell Line, Tumor ; Female ; Humans ; Mice ; Mice, Inbred C57BL ; Neoplasms/immunology ; Recombinant Proteins/genetics

المؤلفون: Jochems, Caroline, Hodge, James W., Fantini, Massimo, Tsang, Kwong Y., Vandeveer, Amanda J., Gulley, James L., Schlom, Jeffrey

مصطلحات موضوعية: Male, Lymphoma, Non-Hodgkin, Receptors, IgG, Antibody-Dependent Cell Cytotoxicity, Antibodies, Monoclonal, Apoptosis, Middle Aged, Antibodies, Monoclonal, Humanized, GPI-Linked Proteins, Article, B7-H1 Antigen, Killer Cells, Natural, Immunoglobulin G, Tumor Cells, Cultured, Humans, Interleukin-2, Cell Proliferation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::3bae6e29d0f5c7dda85942d50817d2b6
https://europepmc.org/articles/PMC5604238/

المؤلفون: Hodge, James W., Guha, Chandan, Jacques Neefjes, Gulley, James L.

المصدر: Publons

مصطلحات موضوعية: Radiotherapy, Neoplasms, Radiation, Ionizing, Antibodies, Monoclonal, Humans, Radiotherapy, Adjuvant, Immunotherapy, Article

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2fb2922dbb1479de2dfd92ea78f97fab
https://publons.com/publon/8467036/